These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mitoxantrone: a review of its use in multiple sclerosis. Scott LJ; Figgitt DP CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110 [TBL] [Abstract][Full Text] [Related]
5. Effect of total lymphoid irradiation in chronic progressive multiple sclerosis. Cook SD; Devereux C; Troiano R; Hafstein MP; Zito G; Hernandez E; Lavenhar M; Vidaver R; Dowling PC Lancet; 1986 Jun; 1(8495):1405-9. PubMed ID: 2872516 [TBL] [Abstract][Full Text] [Related]
6. Effect of total lymphoid irradiation on functional status in chronic multiple sclerosis: importance of lymphopenia early after treatment--the pros. Devereux C; Troiano R; Zito G; Devereux RB; Kopecky KJ; Friedman R; Dowling PC; Hafstein MP; Rohowsky-Kochan C; Cook SD Neurology; 1988 Jul; 38(7 Suppl 2):32-7. PubMed ID: 3290713 [TBL] [Abstract][Full Text] [Related]
9. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study. Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929 [TBL] [Abstract][Full Text] [Related]
10. Clinical drawbacks of total lymphoid irradiation: the cons. Myers LW; Ellison GW; Fahey JL; Tesler A; Gottlieb MS Neurology; 1988 Jul; 38(7 Suppl 2):38-41. PubMed ID: 3386844 [TBL] [Abstract][Full Text] [Related]
11. Total lymphoid irradiation in chronic progressive multiple sclerosis. Capra R; Marcianó N; Mattioli F; Di Monda V; Vignolo LA; Buffoli A; Micheletti E; Magno L Ital J Neurol Sci; 1992 Mar; 13(2):131-4. PubMed ID: 1592573 [TBL] [Abstract][Full Text] [Related]
12. Management of worsening multiple sclerosis with mitoxantrone: a review. Fox EJ Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460 [TBL] [Abstract][Full Text] [Related]
13. A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS. Ramo-Tello C; Grau-López L; Tintoré M; Rovira A; Ramió i Torrenta L; Brieva L; Cano A; Carmona O; Saiz A; Torres F; Giner P; Nos C; Massuet A; Montalbán X; Martínez-Cáceres E; Costa J Mult Scler; 2014 May; 20(6):717-25. PubMed ID: 24144876 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the immunosuppressive effect of fractionated total lymphoid irradiation (TLI) vs conventional immunosuppression (CI) in renal cadaveric allotransplantation. Waer M; Vanrenterghem Y; Ang KK; Van der Schueren E; Michielsen P; Vandeputte M J Immunol; 1984 Feb; 132(2):1041-8. PubMed ID: 6228588 [TBL] [Abstract][Full Text] [Related]
15. Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation. Drachman DB; Chaudhry V; Cornblath D; Kuncl RW; Pestronk A; Clawson L; Mellits ED; Quaskey S; Quinn T; Calkins A Ann Neurol; 1994 Feb; 35(2):142-50. PubMed ID: 8109895 [TBL] [Abstract][Full Text] [Related]
16. A double-blind controlled pilot study of plasma exchange versus sham apheresis in chronic progressive multiple sclerosis. Gordon PA; Carroll DJ; Etches WS; Jeffrey V; Marsh L; Morrice BL; Olmstead D; Warren KG Can J Neurol Sci; 1985 Feb; 12(1):39-44. PubMed ID: 3884114 [TBL] [Abstract][Full Text] [Related]
17. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270 [TBL] [Abstract][Full Text] [Related]
18. [Progressive multiple sclerosis. Evaluation of the effectiveness of total lymph node irradiation]. Buffoli A; Micheletti E; Capra R; Mattioli F; Marcianò N Radiol Med; 1991 Jun; 81(6):899-901. PubMed ID: 1857800 [TBL] [Abstract][Full Text] [Related]
19. The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group. Lancet; 1991 Feb; 337(8739):441-6. PubMed ID: 1671468 [TBL] [Abstract][Full Text] [Related]
20. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Jacobs LD; Cookfair DL; Rudick RA; Herndon RM; Richert JR; Salazar AM; Fischer JS; Goodkin DE; Granger CV; Simon JH; Alam JJ; Bartoszak DM; Bourdette DN; Braiman J; Brownscheidle CM; Coats ME; Cohan SL; Dougherty DS; Kinkel RP; Mass MK; Munschauer FE; Priore RL; Pullicino PM; Scherokman BJ; Whitham RH Ann Neurol; 1996 Mar; 39(3):285-94. PubMed ID: 8602746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]